DNA homologous recombination factor SFR1 physically and functionally interacts with estrogen receptor alpha.
Article Details
- CitationCopy to clipboard
Feng Y, Singleton D, Guo C, Gardner A, Pakala S, Kumar R, Jensen E, Zhang J, Khan S
DNA homologous recombination factor SFR1 physically and functionally interacts with estrogen receptor alpha.
PLoS One. 2013 Jul 9;8(7):e68075. doi: 10.1371/journal.pone.0068075. Print 2013.
- PubMed ID
- 23874500 [ View in PubMed]
- Abstract
Estrogen receptor alpha (ERalpha), a ligand-dependent transcription factor, mediates the expression of its target genes by interacting with corepressors and coactivators. Since the first cloning of SRC1, more than 280 nuclear receptor cofactors have been identified, which orchestrate target gene transcription. Aberrant activity of ER or its accessory proteins results in a number of diseases including breast cancer. Here we identified SFR1, a protein involved in DNA homologous recombination, as a novel binding partner of ERalpha. Initially isolated in a yeast two-hybrid screen, the interaction of SFR1 and ERalpha was confirmed in vivo by immunoprecipitation and mammalian one-hybrid assays. SFR1 co-localized with ERalpha in the nucleus, potentiated ER's ligand-dependent and ligand-independent transcriptional activity, and occupied the ER binding sites of its target gene promoters. Knockdown of SFR1 diminished ER's transcriptional activity. Manipulating SFR1 expression by knockdown and overexpression revealed a role for SFR1 in ER-dependent and -independent cancer cell proliferation. SFR1 differs from SRC1 by the lack of an intrinsic activation function. Taken together, we propose that SFR1 is a novel transcriptional modulator for ERalpha and a potential target in breast cancer therapy.